Artigo Revisado por pares

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

2010; Springer Science+Business Media; Volume: 29; Issue: 3 Linguagem: Inglês

10.1007/s10637-009-9376-8

ISSN

1573-0646

Autores

Evan M. Hersh, Steven O’Day, John D. Powderly, Khuda Dad Khan, Anna C. Pavlick, Lee D. Cranmer, Wolfram E. Samlowski, Geoffrey Nichol, Michael Yellin, Jeffrey S. Weber,

Tópico(s)

Immunotherapy and Immune Responses

Referência(s)